跳至主要内容
临床试验/NCT03945734
NCT03945734已完成不适用

Feasibility of Expressive Helping for Chinese-Speaking Cancer Patients and Survivors

New York University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Meaningfulness of the study

研究概览

简要总结

This study examines the feasibility, cultural-sensitivity, and health effects of the expressive helping intervention by conducting a single-arm trial with Chinese-speaking cancer patients and survivors.

详细描述

This study examines whether expressive helping is feasible and culturally-sensitive for Chinese American cancer patients and survivors. For 20 minutes each week over four weeks, participants choose to write or voice-record their thoughts about cancer by following specific prompts designed to help them process their cancer experiences. During the last week of this reflection exercise, participants write or voice-record an anonymous letter to another Chinese cancer patient by sharing their cancer experience and providing advice and encouragement. Health outcomes are assessed at baseline, 1-month, and 3-month follow-ups. A subset of the participants will be invited to share their experiences with the study through qualitative interviews after the last writing/voice-recording session. This research study provides an opportunity for Chinese American cancer patients and survivors to express their feelings without the fear of burdening others, and give them an opportunity to help others by sharing their cancer experiences.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of cancer (any type)
  • Of Chinese descent
  • Over the age of 18
  • Can speaking and read Mandarin Chinese

排除标准

  • Completed primary cancer treatment more than five years ago

结局指标

主要结局

Meaningfulness of the study

时间窗: This will be assessed approximately four weeks after the baseline

We will ask participants open-ended questions about whether they felt participating in this study was meaningful to them.

Retention rate

时间窗: through study completion, an average of 1 year

Retention rate is calculated by dividing the number of participants who began the study by the number of participants who finished the entire study.

Number of participants screened

时间窗: through study completion, an average of 1 year

The number of participants screened for eligibility will be counted.

Compliance rate

时间窗: through study completion, an average of 1 year

Compliance rate is calculated by dividing the number of writing/voice-recording sessions finished by the number of sessions assigned.

次要结局

  • Change in quality of life as assessed by the Functional Assessment of Cancer Therapy Scale (FACT).(Baseline; 1-month follow-up; 3-month follow-up)
  • Change in depressive symptoms as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D).(Baseline; 1-month follow-up; 3-month follow-up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

撤回
不适用
Culturally-Adapting a Communication Intervention to Improve Palliative Care Literacy on Two Native American ReservationsAdvance Care Planning
NCT03569150South Dakota State University
已完成
不适用
Supportive Expressive Therapy for Depressed and Anxious AdolescentsDepressionAnxiety
NCT00381979Centre for Addiction and Mental Health20
进行中(未招募)
不适用
Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced CancerCancer
NCT05763797M.D. Anderson Cancer Center170
已完成
不适用
Health Benefits of Expressive Writing Among Chinese Breast Cancer SurvivorsBreast NeoplasmsBreast Cancer
NCT02946619University of Houston136
进行中(未招募)
不适用
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal StudyAnatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Prognostic Stage 0 Breast Cancer AJCC v8Prognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8
NCT04754412M.D. Anderson Cancer Center256